Headlines
European shares muted as markets await Ukraine talks after US-Russia summit
Published by Global Banking & Finance Review®
Posted on August 18, 2025
3 min readLast updated: January 22, 2026
Global Banking & Finance Review®
Company
Published by Global Banking & Finance Review®
Posted on August 18, 2025
3 min readLast updated: January 22, 2026
European shares are steady as markets await Ukraine peace talks following a US-Russia summit. Key sectors show mixed performances amid geopolitical tensions.
By Twesha Dikshit and Purvi Agarwal
(Reuters) -European shares were subdued on Monday, ahead of key meetings between Ukraine, European leaders and U.S. President Donald Trump, following a Russia-U.S. summit that ended without an immediate agreement.
The pan-European STOXX 600 index closed 0.1% up, after logging a second straight weekly gain on Friday.
Ukraine's Volodymyr Zelenskiy will meet Trump along with other European leaders in a bid to draw out a peace deal that will not favour Moscow.
Trump met with his Russian counterpart Vladimir Putin on Friday and agreed that a peace deal should be worked upon without a ceasefire.
Europe's index tracking aerospace and defence stocks was up 0.7%, after falling in the last session. UK's Babcock gained 5.2% after RBC initiated the engineering company at "Outperform".
"If we can get to a peace agreement, the market would likely take that positively, but it remains unclear at this stage, given that the two sides seem quite far apart," said Kiran Ganesh, multi-asset strategist at UBS Global Wealth Management.
"We don't have a lot of clarity on how they (important market catalysts) might turn out, so the market has been quite directionless."
Most sectors on the benchmark STOXX 600 were lower, with a 1.6% and 0.5% decline in miners and heavyweight banks weighing the most.
Novo Nordisk jumped 6.6% after the drugmaker's weight-loss drug Wegovy received an accelerated approval by the U.S. Food and Drug Administration to treat a serious liver condition.
Separately, it announced it was offering its diabetes drug Ozempic for $499 per month to eligible patients in the U.S.
The gains boosted the healthcare sector up 1.4%, logging its eighth session of gains. The sector took a beating this year, on uncertainty around Trump's pharma tariffs, but is making a recovery.
Most regional bourses also closed lower, while UK's FTSE 100 managed to eke out a 0.2% gain.
The Federal Reserve's annual Jackson Hole symposium later this week will be in focus, where Chair Jerome Powell and other policymakers will talk economic outlook and the central bank's policy framework.
Ganesh said that investors will be looking out for any candidates who might position themselves more dovish-ly on monetary policy as the Trump administration considers a new Fed Chair.
Vestas shares soared 15%, topping the STOXX 600 after the U.S. Treasury released guidelines for the qualification of wind and solar subsidies, offering clarity for projects through 2030.
Other renewables also gained, with EDP Renonvaveis surging 6.2%, while Orsted and RWE both gained 1% each.
Commerzbank fell 3.2%, the most among banks, after Deutsche Bank downgraded the stock to "Hold" from "Buy".
(Reporting by Twesha Dikshit, Sruthi Shankar and Purvi Agarwal in Bengaluru; Editing by Rashmi Aich and Vijay Kishore)
The Federal Reserve, often referred to as the Fed, is the central bank of the United States responsible for implementing monetary policy and regulating financial institutions.
Monetary policy refers to the actions taken by a central bank to manage the money supply and interest rates to achieve macroeconomic objectives like controlling inflation and stabilizing currency.
Investment opportunities are chances to invest in assets or projects that are expected to yield a return, such as stocks, bonds, real estate, or startups.
Explore more articles in the Headlines category
